Induction of therapeutic levels of HbF in genome-edited primary β 0 39-thalassaemia haematopoietic stem and progenitor cells.

MLA

Mingoia, Maura, et al. “Induction of Therapeutic Levels of HbF in Genome-Edited Primary β 0 39-Thalassaemia Haematopoietic Stem and Progenitor Cells.” British Journal of Haematology, vol. 192, no. 2, Jan. 2021, pp. 395–404. EBSCOhost, https://doi.org/10.1111/bjh.17167.

APA

Mingoia, M., Caria, C. A., Ye, L., Asunis, I., Marongiu, M. F., Manunza, L., Sollaino, M. C., Wang, J., Cabriolu, A., Kurita, R., Nakamura, Y., Cucca, F., Kan, Y. W., Marini, M. G., & Moi, P. (2021). Induction of therapeutic levels of HbF in genome-edited primary β 0 39-thalassaemia haematopoietic stem and progenitor cells. British Journal of Haematology, 192(2), 395–404. https://doi.org/10.1111/bjh.17167

Chicago

Mingoia, Maura, Cristian A Caria, Lin Ye, Isadora Asunis, M Franca Marongiu, Laura Manunza, M Carla Sollaino, et al. 2021. “Induction of Therapeutic Levels of HbF in Genome-Edited Primary β 0 39-Thalassaemia Haematopoietic Stem and Progenitor Cells.” British Journal of Haematology 192 (2): 395–404. doi:10.1111/bjh.17167.